GENE ONLINE|News &
Opinion
Blog

Liquid Biopsy
CK Life Sciences and CK Hutchison Invest in Taiwanese Liquid Biopsy Candidate
2022-07-26
Delfi Diagnostics Amasses $225 Million for Early Cancer Screening
2022-07-19
Freenome Raises $300 Million Series D for Cancer-Detecting Multiomics Platform
2021-12-08
Illumina Completes GRAIL Acquisition Without Approval From FTC
2021-08-19
FDA Approves Foundation Medicine’s Liquid Biopsy Test as Companion Diagnostic for Novartis’ Tabrecta
2021-07-18
Genomic Profiling Reveals Multiple Resistance Mechanisms of Cancers Against KRAS Inhibitors
2021-06-25
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
10 Precision Oncology Companies to Look Out for
2021-05-27
Precision Oncology: Overview of Diagnostic Technologies
2021-05-25
R&D
Mirvie Heralds Liquid Biopsy-Based Test to Predict Pregnancy Complications
2021-04-28
Illumina Enters Yet Another Oncology Partnership to Capitalize on its Pan-Cancer Assay
2021-04-23
M&A
Amidst Battle with FTC, Illumina Faces Scrutiny from EU Over its $7.1B GRAIL Merger
2021-04-20
How Liquid Biopsies are Helping in Detection of Cancer Relapse?
2021-04-17
GeneOnline’s Top 10 Headlines of the Year
2020-12-30
FMI Empowers its Genomic Cancer Testing by Licensing TwinStrand’s Duplex Sequencing Technology
2020-11-18
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top